In diffuse large B-cell lymphoma (DLBCL), LAG-3 was detected by the positive staining in 39% of tumor cells, while TIM-3 expression was associated with poor prognosis. This evidence concerns the gene HAVCR2 and diffuse large B-cell lymphoma.